Drug Profile
Mitotane
Alternative Names: Lisodren; LysodrenLatest Information Update: 06 May 2022
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Developer Bristol-Myers Squibb; HRA Pharma
- Class Antineoplastics; Chlorinated hydrocarbons; Small molecules
- Mechanism of Action Hormone inhibitors; Steroid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Adrenocortical carcinoma